POM Investment Strategies »

Revance Therapeutics shares owned by POM Investment Strategies

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by POM Investment Strategies from 13F filings

Historical chart of POM Investment Strategies investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by POM Investment Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by POM Investment Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $13k 2.6k 4.92
2023-12-31 $23k 2.6k 8.79

More positions owned by POM Investment Strategies

Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Vanguard World Mega Grwth Ind (MGK)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchng Traded Fd Vi Ft Vest Fd Of Bu (BUFR)
First Tr Exchange-traded Dow 30 Eql Wgt (EDOW)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Spdr Dow Jones Indl Average Ut Ser 1 (DIA)
Ishares Tr S&p 500 Val Etf (IVE)
First Tr Exchange-traded Dorsey Wrt 5 Etf (FV)
First Tr Nas100 Eq Weighted SHS (QQEW)
Ishares Tr Ibonds Dec24 Etf (IBDP)
First Tr Exchange-traded Smid Risng Etf (SDVY)
First Tr Exchange-traded Dj Internt Idx (FDN)
Apple (AAPL)

View all positions for POM Investment Strategies

Top funds holding Revance Therapeutics

Capital World Investors
BlackRock
Franklin Resources
Vanguard Group
Palo Alto Investors
Polar Capital Holdings
Jpmorgan Chase & Co
Barclays
Rubric Capital Management
State Street Corporation
Stonepine Capital Management
Geode Capital Management
CIBC Global Asset Management
Suvretta Capital Management
Federated Investors

View all funds holding Revance Therapeutics